Medical Condition News

RSS

Mayo Clinic article provides better understanding on potentially devastating liver disease

An article published today in the New England Journal of Medicine updates the medical community on a potentially devastating liver disease that afflicts approximately 29,000 Americans.

22 Sep 2016

Virginia Tech researchers identify novel compound that blocks growth of deadly fungus

Researchers with the Virginia Tech Center for Drug Discovery have identified a compound that blocks the growth of a fungus that causes deadly lung infections and allergic reactions in people with compromised immune systems.

22 Sep 2016

Scientists find way to reverse malfunctioning protein clumps involved in ALS

In the quest to understand the driving forces behind neurodegenerative diseases, researchers in recent years have zeroed in on clumps of malfunctioning proteins thought to kill neurons in the brain and spinal cord by jamming their cellular machinery.

22 Sep 2016

CUMC researchers uncover new details of intracellular channel that controls skeletal muscle

Using high-resolution electron microscopy, Columbia University Medical Center researchers have uncovered new details of the structure and function of an intracellular channel that controls the contraction of skeletal muscle.

22 Sep 2016

JAK inhibitors may be first effective treatment for people with alopecia areata

Seventy-five percent of patients with moderate to severe alopecia areata—an autoimmune disease that causes patchy, and less frequently, total hair loss—had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center. By the end of their treatment, average hair regrowth was 92 percent.

22 Sep 2016

Tumour suppressor gene has greater anti-cancer activity than previously thought

New insight into the function of a gene important in the suppression of cancer is published today. Researchers at the National University of Ireland Galway have shown that the TP53 gene has even greater anti-cancer activity than previously thought.

22 Sep 2016

Color-deficiency or color-blindness?

Color blindness could be considered a bit of a misleading term, because there are very few people who can't see color at all. Most people have what we call color deficiency or color confusion, which means that they're not blind to color; they just see a reduced number of colors.

From Vision Express 22 Sep 2016

MSK introduces unique program to expand, streamline patient access to high-quality cancer care

In an effort to expand and streamline patient access to its high-quality cancer care, Memorial Sloan Kettering Cancer Center has introduced MSK Direct, a unique program in which MSK collaborates with external employers to simplify how their employees can engage with the institution for initial or ongoing cancer care.

22 Sep 2016

Study shows maritime pine bark extract may be effective in limiting muscle loss due to aging

A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.

22 Sep 2016

Duke, Wisconsin and UAB researchers create bioengineered patches to treat heart failure

The heart cannot regenerate muscle tissue after a heart attack has killed part of the muscle wall, and that dead tissue can strain surrounding muscle, leading to a lethal heart enlargement.

22 Sep 2016

Study examines prevalence of mental disorders in cancer patients

In an investigation published in the current issue of Psychotherapy and Psychosomatics a group of German investigators provides the largest survey of mental disorders in cancer. Psychological problems are common in cancer patients.

22 Sep 2016

Novel immunotherapy shows promise against AML in clinical trial

A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place.

21 Sep 2016

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology.

21 Sep 2016

Mount Sinai and TJU researchers awarded grant for UM research

Uveal melanoma (UM) is the second most common type of skin cancer. Approximately 50 percent of patients will develop metastasis or spread of their cancer, most commonly to the liver.

21 Sep 2016

Bile acid transporter inhibitors can prevent NASH in mice, study shows

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of Atlanta have shown.

21 Sep 2016

ATA announces winner of John B. Stanbury Thyroid Pathophysiology Medal

The American Thyroid Association will present the John B. Stanbury Thyroid Pathophysiology Medal to Kenneth D. Burman, M.D. at the ATA's 86th Annual Meeting, September 21-25, 2016, in Denver, Colorado.

21 Sep 2016

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Brain metastases are one of the most common complications of advanced melanoma, requiring multidisciplinary management.

21 Sep 2016

Three-dimensional heart patches may soon move closer to clinical application

The promise of stem cells to treat cardiovascular disease may soon be a step closer to clinical application as scientists from three institutions seek to perfect and test three-dimensional "heart patches" in a large animal model — the last big hurdle before trials in human patients.

21 Sep 2016

TSRI scientists shed light on molecular workings of MS drug

A study by scientists at The Scripps Research Institute has helped to de-mystify the molecular workings of the multiple sclerosis (MS) drug Tecfidera. The drug is the most widely prescribed pill-based therapy for MS, but its biological mechanism remains mysterious.

21 Sep 2016

New mobile health app may help manage hydroxyurea treatments in sickle cell patients

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has awarded a 6-year, $4.4 million grant to St. Jude Children's Research Hospital and collaborators to improve the use of prescribed medication by sickle cell patients.

21 Sep 2016

Medical Condition News

Mayo Clinic article provides better understanding on potentially devastating liver disease

Virginia Tech researchers identify novel compound that blocks growth of deadly fungus

Scientists find way to reverse malfunctioning protein clumps involved in ALS

CUMC researchers uncover new details of intracellular channel that controls skeletal muscle

JAK inhibitors may be first effective treatment for people with alopecia areata

Tumour suppressor gene has greater anti-cancer activity than previously thought

Color-deficiency or color-blindness?

MSK introduces unique program to expand, streamline patient access to high-quality cancer care

Study shows maritime pine bark extract may be effective in limiting muscle loss due to aging

Duke, Wisconsin and UAB researchers create bioengineered patches to treat heart failure

Study examines prevalence of mental disorders in cancer patients

Novel immunotherapy shows promise against AML in clinical trial

Experimental drug may prevent development of multiple sclerosis in mice

Mount Sinai and TJU researchers awarded grant for UM research

Bile acid transporter inhibitors can prevent NASH in mice, study shows

ATA announces winner of John B. Stanbury Thyroid Pathophysiology Medal

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Three-dimensional heart patches may soon move closer to clinical application

TSRI scientists shed light on molecular workings of MS drug

New mobile health app may help manage hydroxyurea treatments in sickle cell patients

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News